Approval in CSU for children 2 to 11 years of age is based on data from the LIBERTY-CUPID clinical trial program, including an extrapolation of ...

Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous ...

Approval in CSU for children two to 11 years of age is based on data from the LIBERTY-CUPID clinical study program, including an extrapolation of efficacy data showing that Dupixent significantly ...

European Commission approves Sanofi & Regeneron’s Dupixent to treat young children with chronic spontaneous urticaria: Paris Wednesday, April 15, 2026, 09:00 Hrs [IST] The Europ ...

Sanofi wins EC nod to expand Dupixent use to children aged 2 to 11 years with CSU, backed by phase III data, marking the ...

Approval in CSU for children 2 to 11 years of age is based on data from the LIBERTY-CUPID clinical trial program, including an extrapolation of efficacy data showing that Dupixent significantly reduce ...

A BRITISH bakery brand has recalled a number of products over potential rodent contamination. A total of 18 items have been ...

Paid content is paid for and controlled by an advertiser and produced by the Guardian Labs team. It’s the third most common cancer in the UK, causing tens of thousands of deaths annually. But what if ...

My niece was diagnosed with birdshot chorioretinopathy.

PIP is to help those with long-term physical or mental health condition or disability or those who have struggles to complete every day tasks ...